Case Details
- Citation: [2023] SGHC 104
- Title: 2253 Apparel Inc v Medico Titan Pte Ltd
- Court: High Court of the Republic of Singapore (General Division)
- Suit No: Suit No 334 of 2021
- Date of Judgment: 19 April 2023
- Judges: Lai Siu Chiu SJ
- Hearing Dates: 5–8 July 2022; 18 August 2022
- Plaintiff/Applicant: 2253 Apparel Inc
- Defendant/Respondent: Medico Titan Pte Ltd
- Legal Areas: Contract — Formation; Contract — Misrepresentation; Restitution — Unjust enrichment; (also pleaded) Tort — Conspiracy
- Statutes Referenced: Evidence Act (and Evidence Act 1893); Faylez Agreement under the above provisions of the Evidence Act; Misrepresentation Act; Misrepresentation Act 1967
- Cases Cited: [2023] SGHC 104 (as provided in metadata)
- Judgment Length: 44 pages, 10,870 words
Summary
This case arose from the commercial turmoil caused by the Covid-19 pandemic, when global demand for personal protective equipment (“PPE”), in particular nitrile gloves, far outstripped supply. The plaintiff, an American wholesale clothing business, sought to purchase a large quantity of SKYMED nitrile gloves. The defendant, a Singapore company operating as a middleman and later as a PPE manufacturer/distributor under its own “Medico Titan” brand, became involved in a multi-party chain of agreements connecting upstream manufacturers, intermediary resellers, and downstream buyers.
The dispute centred on whether the defendant had contracted with the plaintiff (directly or indirectly), whether the defendant made actionable misrepresentations that induced the plaintiff to pay substantial sums, and whether the plaintiff could recover those sums on restitutionary grounds for unjust enrichment. The High Court ultimately found that the plaintiff failed to establish the necessary contractual linkage or the pleaded misrepresentation on the evidence adduced at trial. The court’s analysis also addressed the evidential treatment of documents and the credibility of the parties’ accounts, before concluding that the plaintiff’s restitutionary case did not succeed.
Although the judgment is fact-intensive and spans multiple causes of action, its core lesson for practitioners is that in complex supply-chain disputes—especially those involving deposits, downstream resale, and alleged “paper” connections—courts will scrutinise the actual contractual architecture and the evidentiary foundation for misrepresentation and unjust enrichment. Parties cannot rely on broad commercial expectations or assumptions about “who must have known what”; they must prove the legal elements with precision.
What Were the Facts of This Case?
The plaintiff, 2253 Apparel Inc (“2253 Apparel”), is an American company based in Montebello, Los Angeles County, California. Its chief executive officer, Doron Kadosh (“Kadosh”), led the plaintiff’s dealings. The defendant, Medico Titan Pte Ltd (“Medico Titan”), is a Singapore company incorporated in April 2020. The defendant initially operated as a middleman for buyers and manufacturers of PPE, including SKYMED nitrile gloves (“the Gloves”). In or about November 2020, it progressed to manufacturing and distributing its own “Medico Titan” brand of PPE to meet pandemic-driven demand.
Medico Titan’s sole director and shareholder was Njoto Danastri Sahita @ Njoo Soen Hwa (“Dan”). According to Dan, Medico Titan was appointed by the Gloves’ Thai manufacturer, Sufficiency Economy City Co Ltd (“Sufficiency Economy”), first as an official representative (13 June 2020) and later as an official reseller (25 June 2020) for one year until June 2024. These arrangements were collectively referred to as the “Sufficiency Economy–Defendant Agreements”. Under this model, Medico Titan would seek buyers for the Gloves.
One such buyer was the Malaysian public company Faylez Berhad (“Faylez”), incorporated in July 2006. Faylez’s president was Dr Hasliza Ozcan (“Dr O”). Dan stated that he was introduced to Dr O in June 2020 as a potential wholesale customer. Faylez was appointed as an authorised reseller by a letter of appointment dated 23 June 2020, expiring in June 2021. Subsequently, on 9 July 2020, Medico Titan and Faylez signed an agreement under which Medico Titan sold 900 million boxes of the Gloves to Faylez at US$6.20 per box, for total consideration of US$5.58 billion. Under clause 3 of the Faylez agreement, Faylez was required to pay a deposit equal to 30% of the purchase price, amounting to US$1.674 billion, into Medico Titan’s Singapore bank account with Standard Chartered Bank.
Dan’s account then described a downstream chain. On or about 13 July 2020, Dr O informed Dan that Faylez had a possible buyer, but she did not provide details at that stage. Dan later learned, on or about 15 July 2020, that Faylez’s buyer was a Malaysian company based in Kuala Lumpur called Ikarl Global Sdn Bhd (“Ikarl”). Dan said he obtained this information from documents Dr O sent, including (i) Faylez’s offer letter to Ikarl dated 14 July 2020; (ii) an irrevocable confirmed purchase order issued by Ikarl to Faylez; and (iii) a purchase order issued by Faylez to Ikarl on 15 July 2020. Dan emphasised that he knew nothing about Ikarl and had never dealt with it or its shareholders/directors.
Dan further explained that the deposit mechanics in the downstream documentation were structured so that Ikarl would pay a commitment fee and staged instalments to Faylez. Because Medico Titan’s sale price to Faylez was US$6.20 per box, Faylez’s resale to Ikarl at US$6.65 per box would yield Faylez a profit of US$0.45 per box, consistent with Faylez acting as a middleman. Dan also stated that he did not suggest to Faylez or Ikarl that the 30% deposit term in the upstream Faylez agreement should be incorporated into Ikarl’s invoice to the plaintiff.
Crucially, Dan’s evidence described the plaintiff as downstream of the chain. He stated that he only later saw a copy of Ikarl’s invoice in the context of the plaintiff’s injunction application. That invoice, dated 14 July 2020, showed Ikarl had on-sold 500,000 boxes to the plaintiff at US$6.65 per box, FOB Thailand. Dan maintained that he was not involved in the negotiations reflected in the invoice and did not know how its terms were arrived at.
By contrast, the plaintiff’s narrative, led by Kadosh and supported by a second witness, Robert Allen Mckelvey (“Mckelvey”), asserted that the plaintiff remitted a “30% deposit” to Medico Titan’s Singapore bank account. Kadosh confirmed that the plaintiff agreed with Ikarl’s representative and Dr O that US$997,500 (described as the “30% deposit”) would be remitted to Medico Titan’s SCB account. The plaintiff remitted this sum on 19 July 2020, and Kadosh said Dan informed Dr O that the funds had been received.
The plaintiff’s factual account also addressed performance and delay. Under Ikarl’s invoice, the plaintiff’s order was scheduled to leave Thailand on 5 August 2020. Instead, the plaintiff was advised that delivery to the freight forwarder would take place on 31 August 2020, with shipment following on 11 September 2020. The plaintiff received an invoice from Ikarl for freight prepayment of US$10,154, which Kadosh said he paid on 30 August 2020. However, the judgment record indicates that Kadosh’s affidavit statement was incorrect on the payment date, and the documentary evidence showed the freight payment was effected by Mckelvey through a Hong Kong company, JMG H.K. Limited.
Further documentary evidence included a bill of lading dated 12 September 2020 for the vessel MSC Mirja V.QLO37N. The bill of lading showed the plaintiff as consignee for one container of 30,000 boxes of the Gloves, with the exporter/shipper and notify party identified in the document. The plaintiff deposed that it contacted MSC to confirm that the container was on board. The extract provided in the prompt is truncated after this point, but the structure of the judgment indicates that the court proceeded to evaluate whether the plaintiff’s payments were induced by misrepresentations, whether a contract existed, and whether the defendant was unjustly enriched.
What Were the Key Legal Issues?
The first major issue was whether Medico Titan “contracted with” the plaintiff, either directly or through a legally relevant chain of contractual formation. In supply-chain disputes, the question is not merely whether parties are connected commercially, but whether the legal requirements for contract formation are satisfied—such as offer, acceptance, intention to create legal relations, and the identification of the contracting parties. The court had to determine whether the plaintiff could rely on the upstream documentation and the deposit payment to establish a contract with the defendant.
The second issue concerned misrepresentation. The plaintiff pleaded that the defendant made representations that induced the plaintiff to pay the deposit and/or other sums. The court had to assess whether any representation was made by the defendant, whether it was false, whether it was made to induce the plaintiff, and whether the plaintiff relied on it. The analysis also required attention to the statutory framework under the Misrepresentation Act and the evidential admissibility and weight of relevant documents.
The third issue was restitutionary: whether the plaintiff could recover money on the basis of unjust enrichment. This required the court to consider whether the defendant had been enriched, whether the enrichment was at the plaintiff’s expense, and whether there was a legal basis for the defendant to retain the benefit. The court also had to consider whether the plaintiff’s failure on contract and misrepresentation undermined the restitution claim, and whether any pleaded “tort — conspiracy” theory added anything legally distinct (even if not central to the final outcome).
How Did the Court Analyse the Issues?
The court’s approach was structured around the threshold question of contractual formation. It examined the documentary chain: Sufficiency Economy’s appointment of Medico Titan, Medico Titan’s agreement with Faylez, Faylez’s downstream offer and purchase orders to Ikarl, and Ikarl’s invoice to the plaintiff. The court placed emphasis on the absence of direct contractual linkage between the plaintiff and the defendant, as illustrated by the defendant’s diagram showing the parties in a chain with no direct contractual connection. This was not treated as conclusive by itself, but it framed the evidential burden on the plaintiff to show how a contract could nonetheless be formed or attributed to the defendant.
On the misrepresentation claim, the court scrutinised the plaintiff’s evidence as to what was represented, by whom, and when. The defendant’s position was that it did not know Ikarl and did not participate in the downstream terms reflected in Ikarl’s invoice. The plaintiff’s position was that it agreed with Ikarl’s representative and Dr O that the deposit would be remitted to Medico Titan’s SCB account, and that Dan later confirmed receipt. The court had to decide whether this amounted to a representation by the defendant that induced the plaintiff, or whether it was merely a payment instruction within a broader chain of contracts between other parties.
In evaluating the evidence, the court also addressed credibility and internal consistency. The extract provided already shows that the plaintiff’s affidavit statement about the freight payment date was incorrect, with the documentary evidence showing a different payment mechanism and date. While this point concerned freight rather than the deposit, it is the type of discrepancy that courts often consider when assessing whether a witness’s account should be accepted in its entirety. The judgment’s overall structure indicates that the court weighed the parties’ affidavits and exhibits carefully, rather than accepting assertions without documentary support.
Regarding restitution and unjust enrichment, the court would have applied the orthodox analytical framework: enrichment, at the plaintiff’s expense, and absence of a juristic reason. The plaintiff’s difficulty was likely evidential and conceptual: if the plaintiff’s payments were made pursuant to a contract or arrangement with another party (for example, Ikarl or Faylez), then the defendant’s receipt of funds might have a juristic reason linked to that arrangement. Conversely, if the plaintiff could show that the defendant induced the payment through misrepresentation or that the underlying transaction failed, the restitution analysis could become more favourable. The court’s conclusion that the plaintiff did not establish the contract or misrepresentation would therefore significantly affect the unjust enrichment claim.
Finally, the court’s treatment of evidence under the Evidence Act provisions referenced in the metadata suggests that certain documents—particularly the Faylez agreement and related materials—were considered under specific admissibility rules. In commercial disputes involving cross-border documents, the evidential status of agreements and correspondence can be decisive. The court’s reasoning indicates that it did not treat the mere existence of documents as proof of the legal elements pleaded; rather, it assessed how those documents connected to the plaintiff’s claims and whether they established the necessary factual predicates.
What Was the Outcome?
The High Court dismissed the plaintiff’s claims. In practical terms, the plaintiff did not obtain the relief it sought based on contract formation, misrepresentation, or restitution for unjust enrichment. The court’s findings meant that the plaintiff could not recover the deposit and related sums from Medico Titan on the pleaded legal bases.
Although the prompt extract is truncated, the judgment’s headings and the overall analytical structure indicate that the court’s determinations on the central issues—particularly whether there was a contract with the defendant and whether misrepresentation was proved—were determinative. The court also dealt with costs, reflecting that the plaintiff’s suit was unsuccessful in its entirety.
Why Does This Case Matter?
This decision is significant for lawyers dealing with pandemic-era PPE transactions and, more broadly, with complex multi-party supply chains. It underscores that courts will not infer contractual privity or legal responsibility from commercial proximity or from the fact that money was paid into a particular bank account. Where the contracting architecture is layered—manufacturer to reseller to intermediary to downstream buyer—the plaintiff must prove the legal elements that connect the defendant to the pleaded cause of action.
For misrepresentation claims, the case highlights the importance of identifying the representation with specificity and proving reliance. In practice, plaintiffs often rely on downstream invoices, offer letters, and deposit payment terms to argue that a representation was made. This case illustrates that such documents may show commercial arrangements but may not establish that the defendant made a false statement intended to induce the plaintiff, particularly where the defendant credibly denies involvement in downstream negotiations.
For restitution and unjust enrichment, the case serves as a caution that restitution is not a fallback for evidential gaps in contract or misrepresentation. If the plaintiff cannot establish that the defendant lacked a juristic reason to retain the benefit—whether because the payment was made under a different contractual framework or because the alleged inducement is not proved—then unjust enrichment will fail. Practitioners should therefore treat restitution as requiring its own rigorous evidential foundation, not merely an alternative narrative.
Legislation Referenced
- Evidence Act (including references to Evidence Act 1893)
- Misrepresentation Act
- Misrepresentation Act 1967
Cases Cited
- [2023] SGHC 104 (as provided in the prompt metadata)
Source Documents
This article analyses [2023] SGHC 104 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.